Similarly to our results, treatment with a JAG1-neutralizing antibody in vivo strongly inhibited brain metastasis growth in triple-negative breast cancer and sensitizes bone metastasis to chemotherapy, without evident toxicity [35,38]. Here, JAG1 is linked to triple-negative breast carcinoma.